Cytomx Therapeutics, Inc. · NASDAQ:CTMX

Point72 Asset Management, L.P. reported a 8.30% stake in Cytomx Therapeutics, Inc. (Schedule 13G)

Event May 12, 2025 · Filed May 14, 2025

Point72 Asset Management, L.P. reported a 8.30% stake in Cytomx Therapeutics, Inc., 13,094,400 shares, as a passive investor on May 12, 2025. Filed May 14, 2025 (Schedule 13G).

Stake
8.30%
Shares
13,094,400
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.8.30%13,094,400
Point72 Capital Advisors, Inc.8.30%13,094,400
Steven A. Cohen8.30%13,094,400

Source

View original at SEC

Related